Filing Details

Accession Number:
0001140361-16-083089
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-19 17:00:37
Reporting Period:
2016-10-17
Filing Date:
2016-10-19
Accepted Time:
2016-10-19 17:00:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1311596 Tobira Therapeutics Inc. TBRA Pharmaceutical Preparations (2834) 030422069
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425851 Pentwater Capital Management Lp 614 Davis Street
Evanston IL 60201
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2016-10-17 4,300 $39.89 3,707,500 No 4 P Indirect By managed account
Common Stock, Par Value $0.001 Per Share Acquisiton 2016-10-17 27,400 $40.10 3,734,900 No 4 P Indirect By managed account
Common Stock, Par Value $0.001 Per Share Acquisiton 2016-10-18 8,300 $40.04 3,743,200 No 5 P Indirect By managed account
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By managed account
No 4 P Indirect By managed account
No 5 P Indirect By managed account
Footnotes
  1. The reporting person is the investment manager for PWCM Master Fund Ltd, an exempted company formed in the Cayman Islands, Pentwater Equity Opportunities Master Fund, Ltd., an exempted company formed in the Cayman Islands, Oceana Master Fund, Ltd., an exempted company formed in the Cayman Islands, Amundi Absolute Return Pentwater Fund Plc, a private fund formed in Ireland, Pentwater Event Driven Cayman Fund Limited, an exempted company formed in the Cayman Islands, Pentwater Merger Arbitrage Master Fund LTD, an exempted company formed in the Cayman Islands, and LMA SPC for and on behalf of MAP 98 Segregated Portfolio, a segregated portfolio company formed in the Cayman Islands, which directly own the shares.